Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,312 public trials 328 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Completed

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

NCT01375777

Conditions
Dyslipidemias, Hypercholesterolemia, Hypercholesterolemia, Autosomal Dominant, 3, +5 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Encinitas, California, United States
  • Research Site Inglewood, California, United States
View all 58 locations
View Trial Details
Completed

Trial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Paediatric Subjects With Genetic Low-Density Lipoprotein (LDL) Disorders

NCT02392559

Conditions
Dyslipidemias, Heterozygous Familial Hypercholesterolemia, Hypercholesterolemia, +4 more
Locations
  • Research Site Farmington, Connecticut, United States
  • Research Site Wilmington, Delaware, United States
  • Research Site Iowa City, Iowa, United States
  • Research Site Towson, Maryland, United States
View all 66 locations
View Trial Details
Completed

Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2

NCT01763827

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemia, +4 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Chandler, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Carmichael, California, United States
View all 83 locations
View Trial Details
Completed

Fish Oil Study for High Triglyceride Levels in Children

NCT00915902

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
Locations
  • A. I. duPont Hospital for Children Wilmington, Delaware, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Thomas Jefferon University Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

NCT01375764

Conditions
Dyslipidemias, Hypercholesterolemia, Hypercholesterolemia, Autosomal Dominant, 3, +5 more
Locations
  • Research Site Anaheim, California, United States
  • Research Site Mission Viejo, California, United States
  • Research Site Westlake Village, California, United States
  • Research Site Atlanta, Georgia, United States
View all 42 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

NCT03011450

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Central Research Associates, Inc. Birmingham, Alabama, United States
  • Central Alabama Research Birmingham, Alabama, United States
  • Cahaba Research, Inc. Birmingham, Alabama, United States
  • Boyett Health Services Inc Hamilton, Alabama, United States
View all 241 locations
View Trial Details

Related conditions